Oral Session 1-13D Transplant Outcomes (2)

[OS1-13D-3] Retrospective analysis of autologous stem cell transplantation for AL amyloidosis

Shinichi Fuchida¹, Koji Kawamura², Nobuhiro Tsukada³, Kumiko Kagawa⁴, Takahiro Karasuno⁵, Hiroshi Ohkawara⁶, Kensuke Usuki⁷, Atsushi Wake⁸, Yukinori Nakamura⁹, Yoshitaka Inoue¹⁰, Takahiro Fukuda¹¹, Tatsuo Ichinohe¹², Yoshiko Atsuta¹³, Kazutaka Sunami¹⁴, Hiroyuki Takamatsu¹⁵ (1.JCHO Kyoto Kuramaguchi Medical Center, Department of Hematology, 2.Jichi Medical University, Saitama Medical Center, Division of Hematology, 3.Japanese Red Cross Medical Center, Department of Hematology, 4.Tokushima University Hospital, Cell Therapy Center, 5.Rinku General Medical Center, Division of Hematology, 6.Fukushima Medical University Hospital, Department of Hematology, 7.NTT Medical Center Tokyo, Department of Hematology, 8.Toranomon Hospital, Kajigaya, Department of Hematology, 9.Yamaguchi University Hospital, Third Department of Internal Medicine, 10.Kumamoto University Hospital, Department of Hematology, 11.National Cancer Center Hospital, Hematopoietic Stem Cell Transplantation Division, 12.Hiroshima University, Department of Hematology and Oncology, 13.Japanese Data Center for Hematopoietic Cell Transplantation, 14.NHO Okayama Medical Center, Department of Hematology, 15.Kanazawa University Graduate School of Medical Science, Department of Hematology)